1. Home
  2. APVO vs ICON Comparison

APVO vs ICON Comparison

Compare APVO & ICON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APVO
  • ICON
  • Stock Information
  • Founded
  • APVO 2016
  • ICON 2023
  • Country
  • APVO United States
  • ICON Greece
  • Employees
  • APVO N/A
  • ICON N/A
  • Industry
  • APVO Biotechnology: Pharmaceutical Preparations
  • ICON
  • Sector
  • APVO Health Care
  • ICON
  • Exchange
  • APVO Nasdaq
  • ICON Nasdaq
  • Market Cap
  • APVO 4.4M
  • ICON 4.7M
  • IPO Year
  • APVO N/A
  • ICON 2024
  • Fundamental
  • Price
  • APVO $4.50
  • ICON $2.23
  • Analyst Decision
  • APVO Strong Buy
  • ICON Strong Buy
  • Analyst Count
  • APVO 1
  • ICON 1
  • Target Price
  • APVO $296.00
  • ICON $7.00
  • AVG Volume (30 Days)
  • APVO 485.4K
  • ICON 54.7K
  • Earning Date
  • APVO 11-07-2024
  • ICON 12-24-2024
  • Dividend Yield
  • APVO N/A
  • ICON 3.55%
  • EPS Growth
  • APVO N/A
  • ICON N/A
  • EPS
  • APVO N/A
  • ICON 0.35
  • Revenue
  • APVO N/A
  • ICON $4,810,000.00
  • Revenue This Year
  • APVO N/A
  • ICON $41.29
  • Revenue Next Year
  • APVO N/A
  • ICON $130.65
  • P/E Ratio
  • APVO N/A
  • ICON $6.38
  • Revenue Growth
  • APVO N/A
  • ICON 5.71
  • 52 Week Low
  • APVO $3.65
  • ICON $1.81
  • 52 Week High
  • APVO $399.60
  • ICON $3.85
  • Technical
  • Relative Strength Index (RSI)
  • APVO 35.34
  • ICON N/A
  • Support Level
  • APVO $3.65
  • ICON N/A
  • Resistance Level
  • APVO $4.78
  • ICON N/A
  • Average True Range (ATR)
  • APVO 1.95
  • ICON 0.00
  • MACD
  • APVO -0.70
  • ICON 0.00
  • Stochastic Oscillator
  • APVO 7.55
  • ICON 0.00

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

About ICON Icon Energy Corp. Common stock

Icon Energy Corp is a Growth-oriented company that operates as a holding company for the purpose of acquiring, owning, chartering and operating dry bulk vessels through its subsidiaries. The company generates its revenues by chartering the Initial Vessels to regional and international dry bulk operators, commodity traders and end users.

Share on Social Networks: